Subcutaneous or Transvenous Defibrillator Therapy
To the Editor: We inquire about the adjudication of shocks in the Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy (PRAETORIAN) trial conducted by Knops and colleagues (Aug. 6 issue). 1 Of the 83 patients in the subcutaneous implantable...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2021-02, Vol.384 (7), p.676-679 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 679 |
|---|---|
| container_issue | 7 |
| container_start_page | 676 |
| container_title | The New England journal of medicine |
| container_volume | 384 |
| creator | Mandrola, John Enache, Bogdan Redberg, Rita F Gallagher, Mark M Leung, Lisa W.M Akhtar, Zaki Kim, Kevin S Belley-Côté, Emilie P McIntyre, William F Sato, Tomohiko Nojiri, Ayumi Knops, Reinoud E van der Stuijt, Willeke Smeding, Lonneke |
| description | To the Editor:
We inquire about the adjudication of shocks in the Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy (PRAETORIAN) trial conducted by Knops and colleagues (Aug. 6 issue).
1
Of the 83 patients in the subcutaneous implantable cardioverter–defibrillator (ICD) group who had shocks labeled as “appropriate,” 11 had shocks for ventricular tachycardia below the cutoff of 180 beats per minute solely because of oversensing of cardiac signals. For example, ventricular tachycardia at a rate of 150 beats per minute could be sensed as 300 beats per minute. Although the device ultimately terminated an arrhythmia in these . . . |
| doi_str_mv | 10.1056/NEJMc2034917 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2491073049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2491071090</sourcerecordid><originalsourceid>FETCH-LOGICAL-c695t-dcd86b48cde4efc2dc7f5432d9f9d0e88211ed89f5109d6a075911a6174d23593</originalsourceid><addsrcrecordid>eNqN0c1LwzAYBvAgipvTm2cZ6MGD1TefbY5jzi-mHpznkiYpdqztTFph_72pmyLiYbmEkB8vT_IgdIzhEgMXV0-Th0dNgDKJ4x3Ux5zSiDEQu6gPQJKIxZL20IH3cwgLM7mPepRyKagQfYRf2ky3japs3fph7YYzpyr_YavueG3zInPFYqGa7ubNOrVcHaK9XC28PdrsA_R6M5mN76Lp8-39eDSNtJC8iYw2ichYoo1lNtfE6DjnjBIjc2nAJgnB2JpE5hyDNEJBzCXGSuCYGRLi0QE6X89duvq9tb5Jy8JrG8J8ZU1JeDDEFNi2lHABW9IQaXuKWaCnf-i8bl0VvqdTIAKUnbpYK-1q753N06UrSuVWKYa06zL93WXgJ5uhbVZa84O_ywvgbA3K0qeVnZf_z_kE-pag6g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2490691094</pqid></control><display><type>article</type><title>Subcutaneous or Transvenous Defibrillator Therapy</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>New England Journal of Medicine</source><creator>Mandrola, John ; Enache, Bogdan ; Redberg, Rita F ; Gallagher, Mark M ; Leung, Lisa W.M ; Akhtar, Zaki ; Kim, Kevin S ; Belley-Côté, Emilie P ; McIntyre, William F ; Sato, Tomohiko ; Nojiri, Ayumi ; Knops, Reinoud E ; van der Stuijt, Willeke ; Smeding, Lonneke</creator><creatorcontrib>Mandrola, John ; Enache, Bogdan ; Redberg, Rita F ; Gallagher, Mark M ; Leung, Lisa W.M ; Akhtar, Zaki ; Kim, Kevin S ; Belley-Côté, Emilie P ; McIntyre, William F ; Sato, Tomohiko ; Nojiri, Ayumi ; Knops, Reinoud E ; van der Stuijt, Willeke ; Smeding, Lonneke</creatorcontrib><description>To the Editor:
We inquire about the adjudication of shocks in the Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy (PRAETORIAN) trial conducted by Knops and colleagues (Aug. 6 issue).
1
Of the 83 patients in the subcutaneous implantable cardioverter–defibrillator (ICD) group who had shocks labeled as “appropriate,” 11 had shocks for ventricular tachycardia below the cutoff of 180 beats per minute solely because of oversensing of cardiac signals. For example, ventricular tachycardia at a rate of 150 beats per minute could be sensed as 300 beats per minute. Although the device ultimately terminated an arrhythmia in these . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMc2034917</identifier><identifier>PMID: 33596366</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Arrhythmia ; Cardiac arrhythmia ; Death, Sudden, Cardiac - prevention & control ; Defibrillators ; Defibrillators, Implantable ; Humans ; Mortality ; Tachycardia ; Ventricle</subject><ispartof>The New England journal of medicine, 2021-02, Vol.384 (7), p.676-679</ispartof><rights>Copyright © 2021 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c695t-dcd86b48cde4efc2dc7f5432d9f9d0e88211ed89f5109d6a075911a6174d23593</citedby><cites>FETCH-LOGICAL-c695t-dcd86b48cde4efc2dc7f5432d9f9d0e88211ed89f5109d6a075911a6174d23593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2034917$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMc2034917$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33596366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mandrola, John</creatorcontrib><creatorcontrib>Enache, Bogdan</creatorcontrib><creatorcontrib>Redberg, Rita F</creatorcontrib><creatorcontrib>Gallagher, Mark M</creatorcontrib><creatorcontrib>Leung, Lisa W.M</creatorcontrib><creatorcontrib>Akhtar, Zaki</creatorcontrib><creatorcontrib>Kim, Kevin S</creatorcontrib><creatorcontrib>Belley-Côté, Emilie P</creatorcontrib><creatorcontrib>McIntyre, William F</creatorcontrib><creatorcontrib>Sato, Tomohiko</creatorcontrib><creatorcontrib>Nojiri, Ayumi</creatorcontrib><creatorcontrib>Knops, Reinoud E</creatorcontrib><creatorcontrib>van der Stuijt, Willeke</creatorcontrib><creatorcontrib>Smeding, Lonneke</creatorcontrib><title>Subcutaneous or Transvenous Defibrillator Therapy</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor:
We inquire about the adjudication of shocks in the Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy (PRAETORIAN) trial conducted by Knops and colleagues (Aug. 6 issue).
1
Of the 83 patients in the subcutaneous implantable cardioverter–defibrillator (ICD) group who had shocks labeled as “appropriate,” 11 had shocks for ventricular tachycardia below the cutoff of 180 beats per minute solely because of oversensing of cardiac signals. For example, ventricular tachycardia at a rate of 150 beats per minute could be sensed as 300 beats per minute. Although the device ultimately terminated an arrhythmia in these . . .</description><subject>Arrhythmia</subject><subject>Cardiac arrhythmia</subject><subject>Death, Sudden, Cardiac - prevention & control</subject><subject>Defibrillators</subject><subject>Defibrillators, Implantable</subject><subject>Humans</subject><subject>Mortality</subject><subject>Tachycardia</subject><subject>Ventricle</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqN0c1LwzAYBvAgipvTm2cZ6MGD1TefbY5jzi-mHpznkiYpdqztTFph_72pmyLiYbmEkB8vT_IgdIzhEgMXV0-Th0dNgDKJ4x3Ux5zSiDEQu6gPQJKIxZL20IH3cwgLM7mPepRyKagQfYRf2ky3japs3fph7YYzpyr_YavueG3zInPFYqGa7ubNOrVcHaK9XC28PdrsA_R6M5mN76Lp8-39eDSNtJC8iYw2ichYoo1lNtfE6DjnjBIjc2nAJgnB2JpE5hyDNEJBzCXGSuCYGRLi0QE6X89duvq9tb5Jy8JrG8J8ZU1JeDDEFNi2lHABW9IQaXuKWaCnf-i8bl0VvqdTIAKUnbpYK-1q753N06UrSuVWKYa06zL93WXgJ5uhbVZa84O_ywvgbA3K0qeVnZf_z_kE-pag6g</recordid><startdate>20210218</startdate><enddate>20210218</enddate><creator>Mandrola, John</creator><creator>Enache, Bogdan</creator><creator>Redberg, Rita F</creator><creator>Gallagher, Mark M</creator><creator>Leung, Lisa W.M</creator><creator>Akhtar, Zaki</creator><creator>Kim, Kevin S</creator><creator>Belley-Côté, Emilie P</creator><creator>McIntyre, William F</creator><creator>Sato, Tomohiko</creator><creator>Nojiri, Ayumi</creator><creator>Knops, Reinoud E</creator><creator>van der Stuijt, Willeke</creator><creator>Smeding, Lonneke</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20210218</creationdate><title>Subcutaneous or Transvenous Defibrillator Therapy</title><author>Mandrola, John ; Enache, Bogdan ; Redberg, Rita F ; Gallagher, Mark M ; Leung, Lisa W.M ; Akhtar, Zaki ; Kim, Kevin S ; Belley-Côté, Emilie P ; McIntyre, William F ; Sato, Tomohiko ; Nojiri, Ayumi ; Knops, Reinoud E ; van der Stuijt, Willeke ; Smeding, Lonneke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c695t-dcd86b48cde4efc2dc7f5432d9f9d0e88211ed89f5109d6a075911a6174d23593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Arrhythmia</topic><topic>Cardiac arrhythmia</topic><topic>Death, Sudden, Cardiac - prevention & control</topic><topic>Defibrillators</topic><topic>Defibrillators, Implantable</topic><topic>Humans</topic><topic>Mortality</topic><topic>Tachycardia</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mandrola, John</creatorcontrib><creatorcontrib>Enache, Bogdan</creatorcontrib><creatorcontrib>Redberg, Rita F</creatorcontrib><creatorcontrib>Gallagher, Mark M</creatorcontrib><creatorcontrib>Leung, Lisa W.M</creatorcontrib><creatorcontrib>Akhtar, Zaki</creatorcontrib><creatorcontrib>Kim, Kevin S</creatorcontrib><creatorcontrib>Belley-Côté, Emilie P</creatorcontrib><creatorcontrib>McIntyre, William F</creatorcontrib><creatorcontrib>Sato, Tomohiko</creatorcontrib><creatorcontrib>Nojiri, Ayumi</creatorcontrib><creatorcontrib>Knops, Reinoud E</creatorcontrib><creatorcontrib>van der Stuijt, Willeke</creatorcontrib><creatorcontrib>Smeding, Lonneke</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mandrola, John</au><au>Enache, Bogdan</au><au>Redberg, Rita F</au><au>Gallagher, Mark M</au><au>Leung, Lisa W.M</au><au>Akhtar, Zaki</au><au>Kim, Kevin S</au><au>Belley-Côté, Emilie P</au><au>McIntyre, William F</au><au>Sato, Tomohiko</au><au>Nojiri, Ayumi</au><au>Knops, Reinoud E</au><au>van der Stuijt, Willeke</au><au>Smeding, Lonneke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subcutaneous or Transvenous Defibrillator Therapy</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2021-02-18</date><risdate>2021</risdate><volume>384</volume><issue>7</issue><spage>676</spage><epage>679</epage><pages>676-679</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>To the Editor:
We inquire about the adjudication of shocks in the Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy (PRAETORIAN) trial conducted by Knops and colleagues (Aug. 6 issue).
1
Of the 83 patients in the subcutaneous implantable cardioverter–defibrillator (ICD) group who had shocks labeled as “appropriate,” 11 had shocks for ventricular tachycardia below the cutoff of 180 beats per minute solely because of oversensing of cardiac signals. For example, ventricular tachycardia at a rate of 150 beats per minute could be sensed as 300 beats per minute. Although the device ultimately terminated an arrhythmia in these . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>33596366</pmid><doi>10.1056/NEJMc2034917</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2021-02, Vol.384 (7), p.676-679 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2491073049 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; New England Journal of Medicine |
| subjects | Arrhythmia Cardiac arrhythmia Death, Sudden, Cardiac - prevention & control Defibrillators Defibrillators, Implantable Humans Mortality Tachycardia Ventricle |
| title | Subcutaneous or Transvenous Defibrillator Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A03%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subcutaneous%20or%20Transvenous%20Defibrillator%20Therapy&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Mandrola,%20John&rft.date=2021-02-18&rft.volume=384&rft.issue=7&rft.spage=676&rft.epage=679&rft.pages=676-679&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMc2034917&rft_dat=%3Cproquest_cross%3E2491071090%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2490691094&rft_id=info:pmid/33596366&rfr_iscdi=true |